Live Breaking News & Updates on Pharmacy Times Oncology|Page 1

Stay updated with breaking news from Pharmacy times oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Optimizing Pharmaceutical Innovation Through AI: A Pathway to Expedited Drug Discovery and Development

Clinical trials are using AI to handle large and complex volumes of data to develop oncology, cardiovascular, and neurologic compounds and to integrate molecular and imaging data. ....

United States , Sumitomo Dainippon Pharma , El Dakrouni , Boston Consulting Group , Cancer Drug Development , Pharmaceuticals Basel , Artificial Intelligence In Pharmaceutical Research , American Chemical Society , Forbes Technology Council , Health Technol Berl , Insilico Medicine , Drug Discovery , Intelligence Applied , Health Technol , Kimblec Revolutionizing Oncology , Artificial Intelligence , Quantum Leap , Pharmacy Times Oncology , Transforming Cancer Drug Discovery , Pharmaceutical Research , Cancer Drug , Recent Pat Anticancer Drug , Anti Cancer Drug Design , Clin Microbiol , Boston Consulting Group March ,

FDA Approves Capivasertib With Fulvestrant for PIK3CA/ALT1/PTEN Alterations Breast Cancer

Capivasertib is indicated for hormone receptor-positive, human epidermal growth factor 2-negative locally advanced or metastatic breast cancer with 1 or more PIK3CA/ALT1/PTEN-alterations. ....

Astrazeneca Pharmaceuticals , Breast Cancer Research , Locally Advanced , For Papers , Pharmacy Times Oncology , Assessment Aid ,

FDA Approves Enzalutamide for Nonmetastatic Castration-Sensitive Prostate Cancer

The approval makes enzalutamide the first and only androgen receptor-signaling inhibitor approved for the treatment of nonmetastatic castration-sensitive prostate cancer with biochemical recurrence at high risk for metastatic. ....

United States , Ahsan Arozullah , Oncology Development At Astellas , Pfizer Inc , European Medicines Agency , Astellas Pharma Inc , Strategic Innovation , Genesiscare United States , South America , Efficacy Study , Enzalutamide Plus Leuprolide , Patients With Nonmetastatic Prostate , For Papers , Pharmacy Times Oncology , Oncology Development , New England Journal ,

Biosimilars, Though Still Expensive, Are the Minimum Helping to Make Cancer Therapies More Accessible

Choosing the best biosimilar based on reimbursement can be challenging. ....

Alana Hippensteele , Pharmacy Times Health , Pharmacy Times Oncology , Pharmacy Times Health System , Pharmacy Times Oncology Edition , Davy James ,

The Progress, Promise of CRISPR

The gene-editing technology has been used successfully in a pediatric patient with T-cell ALL. ....

Alana Hippensteele , Pharmacy Times Health , Pharmacy Times Oncology , Pharmacy Times Health System , Pharmacy Times Oncology Edition , Davy James ,